Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell Tumors

6 Dec 2024

Abstract excerpt

Testicular cancer is the most common cancer among young adult men and has favorable outcomes, with survival rates approaching 99% and over 80% for those with early and advanced stage disease, respectively. Biomarkers play a critical role in the diagnosis, pre-treatment risk stratification, surveillance, and assessment of post-treatment disease response in these men. Traditional serum tumor markers (STMs), which...

Topics

Join the communities discussing this publication.

Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Sarcoma Diagnosis and Treatment
Testicular diseases and treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39685906
DOI: 10.3390/jcm13237448

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell TumorsPMID 39685906Read ↗

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell TumorsSemantic proximity Read ↗

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell TumoursSemantic proximity Read ↗

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell CancerSemantic proximity Read ↗

Improving outcomes in germ cell cancers using miRNASemantic proximity Read ↗

miRNAs and Biomarkers in Testicular Germ Cell Tumors: An UpdateSemantic proximity Read ↗

Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care.Semantic proximity Read ↗

Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell TumoursSemantic proximity Read ↗

The Role of miRNA in Testicular Cancer: Current Insights and Future PerspectivesSemantic proximity Read ↗

Germ cell tumour subtypes display differential expression of microRNA371a-3pSemantic proximity Read ↗

Molecular and biochemical profile of testicular germ cell tumors: Diagnostic implicationsSemantic proximity Read ↗

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor DiagnosisSemantic proximity Read ↗

Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: An overviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.